A number of research firms have changed their ratings and price targets for Caesars Entertainment (NASDAQ: CZR): 6/2/2026 – Caesars Entertainment had its price target raised by Wells Fargo & Company from $26.00 to $31.00. They now have an “equal weight” rating on the stock. 6/1/2026 – Caesars Entertainment had its “hold” rating reaffirmed by […]

A number of firms have modified their ratings and price targets on shares of C3.ai (NYSE: AI) recently: 6/4/2026 – C3.ai had its “underweight” rating reaffirmed by KeyCorp. 6/4/2026 – C3.ai had its price target raised by Morgan Stanley from $6.00 to $7.00. They now have an “underweight” rating on the stock. 6/4/2026 – C3.ai […]

A number of research firms have changed their ratings and price targets for Ooma (NYSE: OOMA): 5/27/2026 – Ooma had its price target raised by Lake Street Capital from $18.00 to $23.00. They now have a “buy” rating on the stock. 5/27/2026 – Ooma was given a new $24.00 price target by UBS Group AG. […]

Several analysts have recently updated their ratings and price targets for Oracle (NYSE: ORCL): 6/9/2026 – Oracle had its “buy” rating reaffirmed by Bank of America Corporation. 6/8/2026 – Oracle had its price target raised by TD Cowen from $250.00 to $300.00. They now have a “buy” rating on the stock. 6/8/2026 – Oracle had […]

Several analysts have recently updated their ratings and price targets for Mechanics Bancorp (NASDAQ: MCHB): 6/4/2026 – Mechanics Bancorp was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”. 6/1/2026 – Mechanics Bancorp was upgraded by Zacks Research to “hold”. 5/28/2026 – Mechanics Bancorp is now covered by Raymond James Financial, Inc.. They set […]

Vera Therapeutics (NASDAQ: VERA) recently received a number of ratings updates from brokerages and research firms: 6/2/2026 – Vera Therapeutics had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $60.00 price target on the stock. 6/2/2026 – Vera Therapeutics had its “outperform” rating reaffirmed by William Blair. 6/2/2026 – Vera […]

A number of research firms have changed their ratings and price targets for Kura Oncology (NASDAQ: KURA): 6/4/2026 – Kura Oncology had its “overweight” rating reaffirmed by Cantor Fitzgerald. 6/4/2026 – Kura Oncology was given a new $24.00 price target by CLSA. 6/4/2026 – Kura Oncology was given a new $24.00 price target by Wells […]

Expand Energy (NASDAQ: EXE) recently received a number of ratings updates from brokerages and research firms: 5/26/2026 – Expand Energy was downgraded by Barclays PLC from “overweight” to “reduce”. 5/26/2026 – Expand Energy was downgraded by Barclays PLC from “overweight” to “equal weight”. They now have a $110.00 price target on the stock, down from […]

Several analysts have recently updated their ratings and price targets for Booz Allen Hamilton (NYSE: BAH): 5/27/2026 – Booz Allen Hamilton is now covered by BNP Paribas Exane. They set a “neutral” rating and a $80.00 price target on the stock. 5/26/2026 – Booz Allen Hamilton had its “hold” rating reaffirmed by TD Cowen. 5/26/2026 […]

Several analysts have recently updated their ratings and price targets for Great Portland Estates (LON: GPE): 5/21/2026 – Great Portland Estates had its “hold” rating reaffirmed by Jefferies Financial Group Inc.. They now have a GBX 323 price target on the stock. 5/21/2026 – Great Portland Estates had its “hold” rating reaffirmed by Berenberg Bank. […]